New Study Unveils Potential Pathway to Lupus Cure

Researchers identify a key immune system imbalance, opening doors to targeted treatments for the autoimmune disease.

Scientists discovered that an imbalance in T cells is central to lupus development.
The aryl hydrocarbon receptor (AHR) pathway plays a crucial role in regulating immune responses.
Activating AHR or reducing interferon levels could reduce disease-causing cells in lupus patients.
Current treatments broadly suppress the immune system, often leading to significant side effects.
Further research is needed to translate these findings into safe and effective clinical therapies.